AMBULATORY BLOOD-PRESSURE AND URINARY ALBUMIN EXCRETION IN DIABETIC (NON-INSULIN-DEPENDENT AND INSULIN-DEPENDENT) HYPERTENSIVE PATIENTS - RELATIONSHIPS AT BASE-LINE AND AFTER TREATMENT BY THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR TRANDOLAPRIL
B. Bauduceau et al., AMBULATORY BLOOD-PRESSURE AND URINARY ALBUMIN EXCRETION IN DIABETIC (NON-INSULIN-DEPENDENT AND INSULIN-DEPENDENT) HYPERTENSIVE PATIENTS - RELATIONSHIPS AT BASE-LINE AND AFTER TREATMENT BY THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR TRANDOLAPRIL, American journal of hypertension, 11(9), 1998, pp. 1065-1073
The aim of the present study was to examine the relationships between
ambulatory blood pressure (ABPM) and urinary albumin excretion (UAE) i
n diabetic (non-insulin dependent [NIDDM] and insulin-dependent [IDDM]
) hypertensives at baseline and after treatment by an angiotensin conv
erting enzyme (ACE) inhibitor. After a 3-week placebo period, patients
were treated for 16 weeks with trandolapril, 2 to 4 mg/day. The UAE a
nd blood pressure (mercury sphygmomanometer and 24-h ABPM) were measur
ed at baseline and repeated on trandolapril. Predictive factors of abn
ormal UAE (24-h UAE greater than or equal to 30 mg) were determined us
ing univariate and multivariate analysis (logistic regression). Predic
tors of UAE decrease were also searched. One hundred seventy-one patie
nts entered the analysis. Baseline office BP was 164 +/-e 14/97 +/- 6
mm Hg and 24-h BP was 142 +/- 17/83 +/- 10 mm Hg. Seventy-four patient
s (43%) had UAE greater than or equal to 30 mg. Independent risk facto
rs for abnormal UAE were nighttime diastolic BP (odds ratio [OR] = 4.1
, confidence interval [CI] = 2.0 to 8.6, P = .0001), diabetes duration
(OR = 2.4, CI = 1.1 to 5.0, P = .025), and presence of retinopathy (O
R = 3.2, CI = 1.0 to 10.0, P = .047). Conversely office BP level was n
ot significantly related to UAE. On treatment, office BP levels decrea
sed to 143 +/- 13/82 +/- 8 mm Hg (P < .0001) and 24-h BP levels to 134
+/- 17/78 +/- 9 mm Hg (P < .0001). In the abnormal UAE group, UAE sig
nificantly decreased from 76 to 50 mg/day (P = .006). After treatment,
independent predictive factors of abnormal UAE were: on-drug fasting
plasma glucose (OR = 3.5, CI = 1.7 to 7.4, P = .0009) and on-drug nigh
ttime diastolic BP (OR = 3.5, CI = 1.7 to 7.4, P = .001). The only pre
dictor of UAE decrease was a 24-h systolic BP decrease (OR = 2.3, CI =
1.3 to 4.3, P = .007). We conclude that in diabetic hypertensives wit
h abnormal UAE, trandolapril exhibited a sustained 24-h antihypertensi
ve effect and provided a consistent reduction of microalbuminuria. Thi
s study confirmed the superiority of ABPM over clinical BP to predict
target organ damage. Am J Hypertens 1998;11:1065-1073 (C) 1998 America
n Journal of Hypertension, Ltd.